✦ LIBER ✦

6LBA The benefit of regional irradiation in stage I–III breast cancer: 10 years results of the EORTC ROG and BCG phase III trial 22922/10925

✍ Scribed by Struikmans, H.; Collette, S.; Van den Bogaert, W.; Kirkove, C.; Budach, V.; Maingon, P.; Valli, M.C.; Fourquet, A.; Bartelink, H.; Poortmans, P.

Book ID: 122243186
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 46 KB
Volume: 50
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(14)70114-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

EORTC randomised phase III trial 22922/1

EORTC randomised phase III trial 22922/10925 investigating the role of internal mammary chain (IMC) irradiation in stage I-III breast cancer: A quality assurance report on the dummy run

✍ Ph. Poortmans; W. van den Bogaert; J. Venselaar; G. van Tienhoven; H. Struikmans 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 149 KB

6N Irradiation of the internal mammary a

6N Irradiation of the internal mammary and medial supraclavicular lymph node chain in stage I to III breast cancer: state of the day of EORTC phase III trial 22922/10925 with 4004 patients

✍ P. Poortmans; A. Fourquet; L. Collette; H. Struikmans; H. Bartelink; C. Kirkove; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Quality assurance of EORTC trial 22922/1

Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary—medial supraclavicular irradiation in stage I-III breast cancer: the individual case review

✍ P. Poortmans; V.E. Kouloulias; J.L. Venselaar; H. Struikmans; J.B. Davis; D. Huy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 161 KB

48 Oral Quality assurance of the EORTC t

48 Oral Quality assurance of the EORTC trial 22922/10925 investigating the role of internal mammary-medial supraclavicular (IMMS) irradiation in stage I–III breast cancer: early eligibility and treatment compliance check

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Mature results of a phase III randomized

Mature results of a phase III randomized trial of bacillus Calmette–Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I–III melanoma (E1673) : A trial of the Eastern Cooperative Oncology Group

✍ Sanjiv S. Agarwala; Donna Neuberg; Yuhyun Park; John M. Kirkwood 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## BACKGROUND The local and systemic effects of bacillus Calmette–Guerin (BCG) have been known for decades. To investigate the adjuvant effect of BCG on resected American Joint Committee on Cancer (AJCC) Stage I–III melanoma, the Eastern Cooperative Oncology Group conducted a large tri